- 藥品外觀
- 劑量及用法每日一次,早餐
- 劑量調整eGFR > 45: No adjustment necessary. eGFR < 45: 2.5 mg once daily. ESRD requiring hemodialysis: 2.5 mg once daily; administer following hemodialysis. Concomitant Use with Strong CYP3A4/5 Inhibitors: 2.5 mg once daily.
- 最大劑量
- 注射劑配製時溶液限制
- 品牌BRISTOL-MYERS SQUIBB
- 許可證號衛署藥輸字第025221號藥品仿單查詢平台
- 健保代碼BC25221100健保規範查詢
- 健保給付規定
- ATC碼A10BH03
- ATC藥理分類


